Connect Biopharma Holdings Limited Ordinary Shares

CNTBNASDAQUSD
1.22 USD
0.11 (7.95%)AT CLOSE (11:59 AM EDT)
1.24
0.02 (2.06%)
POST MARKET (AS OF 07:30 PM EDT)
Post Market
AS OF 07:30 PM EDT
1.24
0.02 (2.06%)
🔴Market: CLOSED

Shares of Connect Biopharma Holdings Limited Ordinary Shares (CNTB) are trading at $1.22. The stock presents a bearish profile across the board: technical indicators signal "Strong Sell" and our fundamental models agree with a "Sell" rating. This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 1/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On the valuation front, CNTB trades at elevated multiples relative to its peers, earning a "Richly Valued" assessment.

Technical & fundamental data as of Sep 22, 2026.

Open?$1.28
High?$1.28
Low?$1.21
Prev. Close?$1.32
Volume?1.2M
Avg. Volume?1.5M
VWAP?$1.24
Rel. Volume?0.83x
Bid / Ask
Bid?$1.20 × 4.1K
Ask?$1.25 × 9.6K
Spread?$0.05
Midpoint?$1.23
Valuation & Ratios
Market Cap?83.1M
Shares Out?63.0M
Float?13.7M
Float %?21.8%
P/E Ratio?N/A
P/B Ratio?3.09
EPS?-$1.10
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Connect Biopharma Holdings Ltd is a clinical-stage biopharmaceutical company dedicated to transforming care for asthma and chronic obstructive pulmonary disease (COPD). The company is advancing rademikibart, a next-generation antibody designed to target interleukin-4-receptor alpha. It is currently conducting clinical studies of rademikibart for the treatment of acute exacerbations of asthma and COPD. The company operates in one operating segment: treatment of respiratory diseases.
Employees
64
Market Cap
83.1M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2025-09-03
Address
3580 CARMEL MOUNTAIN ROAD, SUITE 200
SAN DIEGO, CA 92130
Phone: 858-727-1040
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bearish(-3/3)
Medium-Term (Wave)? Bearish(-3/3)
Short-Term (Ripple)? Bearish(-1/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
6
Z-Score?
0
Momentum?
50
Short Sent.?
35
Piotroski F-Score?1/9Weak
Altman Z-Score?-15.75Distress
Confidence?58%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?14.49%High
Short Interest?2.0M
Days to Cover?4.2
Free Float13.7M
Avg Daily Volume476.9K
Settlement Date2026-08-31
Financial Health
Current Ratio?2.37Strong
Quick Ratio?2.37Strong
Cash Ratio?1.66Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
58/100
P/E?
N/A
P/B?
Peers
100
S&P
54
3.09FAIR
P/S?
Peers
100
S&P
3
28.15HIGH
P/FCF?
N/A
EV/EBITDA?
S&P
97
-0.8CHEAP
EV/Sales?
Peers
100
S&P
3
19.00HIGH
Returns & Efficiency
ROE?
S&P
3
-257.9%WEAK
ROA?
S&P
3
-159.4%WEAK
Cash Flow & Enterprise
FCF?$-60633000
Enterprise Value?$56.1M
Fundamentals ratios updated end of day